Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

European Journal of Immunology

Volumn 32, Issue 1, 2002, Pages 30-38

  Chiriva Internati, Maurizio ^b,d   Liu, Yong ^a   Salati, Emanuela ^b   Zhou, Weiping ^a   Wang, Zhiqing ^b   Grizzi, Fabio ^c   Roman, Juan J ^a   Lim, Seah H ^b   Hermonat, Paul L ^a,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c Instituto Nationale Tumori   (Italy)

^d Harrington Cancer Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adeno associated virus; Cervical cancer; Dendritic cell; Human papillomavirus E7; Integration

Indexed keywords

APOLIPOPROTEIN E7; B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ARTICLE; ASSAY; CANCER CELL; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GENE CLUSTER; GENE DELIVERY SYSTEM; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX CANCER; WART VIRUS;

ANTIGENS; DENDRITIC CELLS; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-4; ONCOGENE PROTEINS, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0036147989     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200201)32:1<30::AID-IMMU30>3.0.CO;2-E     Document Type: Article

References (34)

1. The dendritic cell system and its role in immunogenicity
2. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
3. Proliferating dendritic cell progenitors in human blood
4. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
5. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation and T helper cell I-associated cytokines
6. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
7. Generation of tumor-specific cytotoxic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope
8. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors
9. Induction of protective antitumor immunity by gene-modified dendritic cells
10. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction
11. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro
12. Generation of an MHC class I restricted cytotoxic T cell response against autologous cervical cancer tumor cells by lipofection of synthetic human papillomavirus types 16 and 18 E7 protein into primary dendritic cells
13. Development, characterization, and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus E7
14. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein
15. Transduction and utility of the granulocyte macrophage-colony stimulating factor gene into monocytes and dendritic cells by adeno-associated virus
16. Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells
17. Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector
18. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells
19. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood
20. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells
21. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
22. High-efficiency transfer of the T cell co-stimulatory molecule 87-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors
23. Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients
24. + human hematopoietic progenitor cells after transduction
25. + hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
26. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo
27. Interaction within clusters of dendritic cells and helper T cells during initial Th1/Th2 commitment
28. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: Role of cluster formation, CD40 and HLA-class II for dendritic cell activation
29. Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters
30. Isolation and characterization of tumor-infiltrating lymphocytes from cervical cancer
31. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific cytolytic T lymphocytes
32. Characterization of accessory molecules in murine lung dendritic cell function: Roles of CD80, CD86, CD54, and CD40L
33. Packaging capacity of adeno-associated virus and the potential for wild type-plus AAV gene therapy vectors
34. + T cell clones during activation or tolerance induction